Evidence map›Paper›PMID 27303044›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Defining chromosomal translocation risks in cancer.

Marc A Hogenbirk, Marinus R Heideman, Iris de Rink, Arno Velds, Ron M Kerkhoven, Lodewyk F A Wessels, Heinz Jacobs

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Chromothripsis.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  4. Article
  5. Generalizations of the genomic rank distance to indels.Bioinformatics (Oxford, England) · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Marc A HogenbirkDivision of Biological Stress Response, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; m.hogenbirk@bluebee.com h.jacobs@nki.nl.
Marinus R HeidemanDivision of Biological Stress Response, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands;
Iris de RinkGenomics Core Facility, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands;
Arno VeldsGenomics Core Facility, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands;
Ron M KerkhovenGenomics Core Facility, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands;
Lodewyk F A WesselsDivision of Molecular Carcinogenesis, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Heinz JacobsDivision of Biological Stress Response, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; m.hogenbirk@bluebee.com h.jacobs@nki.nl.
The Netherlands Cancer Institute · NLCancer Genomics Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosomal translocations are a hallmark of cancer. Unraveling the molecular mechanism of these rare genetic events requires a clear distinction between correlative and causative risk-determinants, where technical and analytical issues can be excluded. To meet this goal, we performed in-depth analyses of publicly available genome-wide datasets. In contrast to several recent reports, we demonstrate that chromosomal translocation risk is causally unrelated to promoter stalling (Spt5), transcriptional activity, or off-targeting activity of the activation-induced cytidine deaminase. Rather, an open chromatin configuration, which is not promoter-specific, explained the elevated translocation risk of promoter regions. Furthermore, the fact that gene size directly correlates with the translocation risk in mice and human cancers further demonstrated the general irrelevance of promoter-specific activities. Interestingly, a subset of translocations observed in cancer patients likely initiates from double-strand breaks induced by an access-independent process. Together, these unexpected and novel insights are fundamental in understanding the origin of chromosome translocations and, consequently, cancer.

Indexed as

Translocation, GeneticAnimalsChromatinGenomeHumansMiceNeoplasmsNuclear ProteinsPromoter Regions, GeneticTranscriptional Elongation FactorsTranscription, GeneticChromatinNuclear ProteinsSUPT5H protein, humanTranscriptional Elongation Factorsactivation-induced cytidine deaminasecancerchromosomal translocationmultiomicspaired integrative analysis

Identifiers

PMID27303044
PMCPMC4932958
OpenAlexW2434564083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.